October 01, 2025 a 09:01 am
CAH: Analysts Ratings - Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) is currently experiencing a stable phase in terms of analyst ratings. The recent trends show a predominance of 'Buy' ratings, with a significant decrease in 'Strong Buy' positions over the past months. Investors seem cautiously optimistic, balancing potential growth in the healthcare sector with macroeconomic uncertainties.
Historical Stock Grades
The recent analyst ratings for Cardinal Health, Inc. reveal the following distribution as of September 2025:
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 10 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the past months, there has been a notable shift in analyst sentiment:
- The total volume of recommendations has slightly decreased, implying a more cautious approach among analysts.
- 'Strong Buy' ratings have decreased, while 'Buy' ratings dominate, showcasing cautious optimism.
- 'Hold' ratings have remained relatively stable, reflecting neutrality in market sentiment.
Percentage Trends
Looking at the percentage distribution of these ratings over time:
- Strong Buy ratings decreased from an earlier position of 15% to only 5% in recent months.
- Buy ratings, however, have consistently represented the majority, indicating continued confidence.
- A gradual decrease in Hold recommendations hints at a clearer direction in market sentiment towards Buy.
- Overall sentiment suggests a conservative optimism with the majority leaning towards maintaining Buy ratings.
Latest Analyst Recommendations
The most recent analyst recommendations are as follows:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-13 | Outperform | Outperform | Baird |
| 2025-08-13 | Outperform | Outperform | Evercore ISI Group |
| 2025-08-13 | Overweight | Overweight | Wells Fargo |
| 2025-08-12 | Outperform | Outperform | Leerink Partners |
| 2025-07-16 | Overweight | Overweight | Morgan Stanley |
Analyst Recommendations with Change of Opinion
These recommendations have recently seen a change in analyst opinion:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-03 | Overweight | Equal Weight | Wells Fargo |
| 2025-02-05 | Buy | Hold | Jefferies |
| 2025-01-08 | Buy | Hold | TD Cowen |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2025-01-06 | Buy | Neutral | B of A Securities |
Interpretation
The overall sentiment suggests a cautiously optimistic outlook for Cardinal Health, Inc. The latest analyst recommendations indicate stability and a positive bias towards the stock, with no significant increase in sell ratings. The shift from 'Hold' to 'Buy' and 'Overweight' suggests an increasing confidence in the company's future performance, even amidst macroeconomic uncertainties. Analysts appear to maintain a steady opinion, reflecting strategic market positioning and potential advantages within the healthcare sector.
Conclusion
Cardinal Health, Inc. presents a stable investment opportunity with cautiously optimistic analyst sentiment. The trend towards 'Buy' and 'Overweight' ratings signals an underlying confidence in the company's strategic direction and market position. However, the decrease in 'Strong Buy' ratings suggests a prudent approach given external market conditions. Overall, Cardinal Health remains a compelling stock with potential for growth, supported by its integrated services and international presence in the healthcare sector.